Are these battered FTSE 100 6% and 8% yielders about to spring higher again?

These FTSE 100 (INDEXFTSE: UKX) dividend stocks have slumped over the past year. Is now the time to buy?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

If you’re scouring the FTSE 100 for big dividend payers, both Centrica (LSE: CNA) and Micro Focus International (LSE: MCRO) could, at first glance, appear to be very tasty destinations for your cash.

British Gas owner Centrica has always been a popular pick for income investors, thanks to the traditionally-defensive nature of its operations. And right now, it carries a monster forward yield of 8.1%, making it one of the best payers on the Footsie.

The rate at which Micro Focus has been raising shareholder payouts over the past five years — 120%, to be exact — has also made it one to watch for dividend chasers. What’s more, as of today, it also carries a large prospective yield of 6.4%.

But are they great buys, or simply investment traps?

Running out of gas

Centrica’s share price remains down 13% from early November 2017, although a resurgent crude price has enabled it to recover some ground and bounce from February’s 20-year lows.

I can’t see the business continuing its more-recent recovery, however. As Morgan Stanley just commented, the relentless rise in US oil production, allied with what it describes as “strong” output increases from major producers Saudi Arabia, Russia, Kuwait, Iraq and the United Arab Emirates, means that black gold values are likely to remain stuck at current levels over the next six months, at least.

Even more worryingly, the steady deterioration in British Gas’s customer base looks set to continue. Latest trading numbers in August showed another shocking decline in account numbers during the first half of 2018. And the number is only likely to keep growing as increasingly-pressured household budgets prompt energy customers to continue switching to cheaper suppliers.

Centrica has cut the dividend three times in the past five years in a sign of the growing stress on its bottom line, and its mountainous debt pile. The City is expecting another reduction this year, to 11.9p per share, from 12p in 2017. I’m expecting a much bigger cut, though, and particularly given that the current projection is barely covered by anticipated earnings.

Getting better?

So is Micro Focus a better choice? Its own share price is also down 52% since a year ago, the damage being done in March after it released yet another profit warning due to integration problems concerning its recently-acquired Hewlett Packard Enterprises’ (HPE) division.

Now trading has been better of late, the tech titan advising this week that it has seen “improved revenue trajectory in the second half of the year” and, as a consequence, commenting that it would hit the upper end of its guided 6-9% sales rise (at constant currencies) for the year to October.

There’s no guarantee that HPE won’t throw up additional problems further down the line. But arguably, these risks are baked into Micro Focus’s low, low forward P/E ratio of 8.1 times for the new period. What’s more, the projected 106 US cent per share dividend for fiscal 2019 is covered 2 times by anticipated earnings, bang on the widely-regarded safety benchmark.

Centrica’s prospective P/E ratio of 11.7 times also makes it cheap on paper. That said, given that it appears a dead cert to endure significant profits pressure well beyond the near term, I don’t think investors should touch it with a bargepole today.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has recommended Micro Focus. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »

Businessman hand stacking money coins with virtual percentage icons
Investing Articles

Here’s how investors can aim for £11,363 a year in passive income from £20,000 in this overlooked FTSE media gem

I think this media stock is commonly overlooked by investors looking for high passive income, but it shouldn’t be, given…

Read more »